Asthma and rhinitis /
Saved in:
| Edition: | 2nd ed. |
|---|---|
| Imprint: | Oxford ; Malden, MA, USA : Blackwell Science, 2000. |
| Description: | 2 v. : ill. ; 29 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4353983 |
Table of Contents:
- Contributors
- Foreword
- Preface to Second Edition
- Preface to First Edition
- Volume 1.
- Part 1. Disease Classification
- 1. Asthma: clinical descriptions and definitions
- 2. Rhinitis: the spectrum of the disease
- Part 2. Epidemiology
- 3. Epidemiology of asthma
- 4. Epidemiology of rhinitis
- 5. Epidemiology of occupational asthma
- 6. Epidemiology of asthma mortality
- Part 3. Genetics
- 7. Genetic approaches to studying asthma
- 8. Antigen and transgenic modelling of asthma and airways hyperreactivity
- 9. The use of small animal models in the study of asthma
- 10. Genetics of atopy
- 11. Genetics of asthma and bronchial hyperresponsiveness
- 12. Genetic and molecular regulation of [beta subscript 2]-adrenergic receptors
- Part 4. Anatomy, Development and Physiology
- 13. Nasal airways
- 14. Structural, immunological and neural elements of the normal human airway wall
- Part 5. Pathology
- 15. The pathology of fatal asthma
- 16. The pathology of asthma of varying severity
- 17. Bronchoalveolar lavage in studies of asthma
- 18. Nasal polyposis: a model of chronic airways inflammation
- 19. Allergic and non-allergic rhinitis
- Part 6. Mast Cells and Basophils
- 20. Development and maturation of mast cells and basophils
- 21. Mast cells and basophils: IgE and its receptors
- 22. Human mast cells and basophils: heterogeneity and mediators
- 23. Mechanisms of mast cell activation
- 24. Mast cells in rhinitis
- 25. Mast cells in asthma
- 26. Basophils in airways disease
- Part 7. Eosinophils
- 27. Human eosinophils--development, maturation and functional morphology
- 28. Mechanisms of eosinophil activation
- 29. Eosinophil mediators
- 30. The eosinophil and asthma
- 31. Eosinophils and rhinitis
- Part 8. Neutrophils and Platelets
- 32. Neutrophils and their mediators in asthma
- 33. Neutrophils and asthma
- 34. Platelets
- Part 9. Lymphocytes
- 35. Mucosa-associated lymphoid tissue of the lung: localization, numbers and dynamics of lymphoid cells in the five different compartments
- 36. Lymphocyte substances in allergic diseases
- 37. Cytokines in allergic airway disease
- 38. Regulation of immunoglobulin Esynthesis
- 39. The lymphocyte in asthma
- 40. The lymphocyte in rhinitis
- 41. Functional heterogeneity of T-lymphocytes in the development of airway hyperresponsiveness
- Part 10. Macrophages, Monocytes and Dendritic Cells
- 42. Alveolar macrophages in asthma
- 43. Professional antigen-presenting cells
- 44. Antigen presentation in the asthmatic lung
- Part 11. Microvasculature
- 45. The role and contribution of adhesion molecules to asthma and pulmonary disease
- 46. Leukocyte-endothelial adhesion
- 47. Microvascular anatomy of the airways
- 48. In vivo processes of exudative airway inflammation with ultimate eosinophil activation and epithelial injury-repair
- 49. Vascular mechanisms in asthma
- Part 12. Epithelial Cells
- 50. Structure, composition and function of airway surface liquid
- 51. Mediator functions of epithelial cells
- 52. Regulation of epithelial-leukocyte interaction and epithelial immune-response genes
- 53. Epithelial cells: regulation of mucus secretion
- 54. Epithelial damage in asthma
- 55. Epithelial cell dysfunction in rhinitis
- Part 13. Neuroregulation
- 56. Neuroanatomy of the airways
- 57. Functional activity of lower airway nerves
- 58. Airway neuropeptides
- 59. Neural reflex pathways in rhinitis
- 60. Muscarinic receptors
- 61. Neural regulation of the immune response
- 62. Neuroregulation of mucosal vasculature
- Part 14. Mediators of Inflammation
- 63. Histamine and its receptors
- 64. The roles of neutral proteases in asthma and rhinitis
- 65. Prostanoids
- 66. Leukotrienes
- 67. Adenosine: its contribution to our understanding of asthma
- 68. Chemokines and eosinophils
- 69. Kinins
- 70. Chemokines
- Index
- Volume 2.
- Part 15. Role of Allergens in Airway Disease
- 71. Aerobiology
- 72. The molecular biology of allergens
- 73. House-dust mite proteinase allergens and their interaction with the bronchial epithelium
- 74. The role of house-dust mite and other allergens in asthma
- 75. The early and late asthmatic response to allergen
- 76. Primary allergic sensitization to inhalant allergens: adult responder phenotype is determined during early childhood
- 77. The role of environmental allergens in rhinitis
- Part 16. Pathophysiology
- 78. Animal models of asthma
- 79. Animal models of rhinitis
- 80. Airway mechanics in asthma
- 81. Airway hyperresponsiveness
- 82. Nasal hyperresponsiveness
- 83. Inflammatory mechanisms in airway hyperresponsiveness
- 84. Mechanisms of cough
- 85. Mechanisms of nocturnal asthma
- 86. Aspirin-sensitive asthma
- 87. Transcription factors in asthma
- 88. Interrelationship between asthma and chronic obstructive pulmonary disease
- 89. Intrinsic asthma
- Part 17. Smooth Muscle Response
- 90. The physiology of airway smooth muscle, and its dynamics in the bronchial wall during development and in maturity
- 91. The role of inflammation in the regulation of airway smooth muscle cell function and growth
- 92. Airway smooth muscle dysfunction in asthma
- 93. Epithelial control over smooth-muscle responsiveness
- Part 18. Exercise-Induced Asthma
- 94. Exercise-induced asthma: clinical manifestations
- 95. Dry-air and hyperosmolar challenge in asthma and rhinitis
- 96. Vascular mechanisms in exercise-induced asthma
- Part 19. Infectious Mechanisms in Asthma and Rhinitis
- 97. Common colds and respiratory viruses
- 98. Effects of viral infections on lower airway function
- 99. Otitis media and sinusitis
- Part 20. Mechanisms of Action of Drugs for the Treatment of Asthma and Rhinitis
- 100. Mechanisms of action of [beta subscript 2]-adrenoceptor agonists
- 101. Methylxanthines and phosphodiesterase inhibitors
- 102. Glucocorticoids in asthma and rhinitis
- 103. Glucocorticoid-insensitive bronchial asthma
- 104. Non-steroidal antiinflammatory drugs in asthma
- 105. Immunosuppressants
- 106. Antileukotrienes
- 107. Antihistamines in rhinitis and asthma
- 108. Antiallergic and vasoactive drugs for rhinitis
- 109. Activation of allergen-reactive T-lymphocytes and mechanisms of hyposensitization
- 110. Specific immunotherapy in allergic rhinitis and asthma
- 111. Antiallergic drugs
- 112. Drug delivery devices and propellants
- Part 21. Clinical Management of Asthma
- 113. Diagnosis in adults
- 114. Prevention of asthma
- 115. Treatment of chronic asthma
- 116. Education and training
- 117. The health economics of asthma
- 118. Outcome measures in asthma management
- Part 22. Asthma in Special Circumstances
- 119. Asthma and rhinitis during pregnancy
- 120. Asthma and surgery
- 121. Management of exercise-induced bronchoconstriction
- 122. Critical care management
- 123. Recalcitrant asthma
- 124. Anaphylaxis
- 125. Asthma in the elderly
- Part 23. Management of Asthma in Childhood
- 126. The wheezing infant and young child
- 127. Development of asthma through childhood
- 128. Asthma through childhood
- 129. Treatment of chronic asthma
- 130. The management of acute severe asthma in children
- 131. Risk-benefit of asthma therapy in children: topical corticosteroids
- 132. Risk-benefit of asthma therapy: non-steroidal antiinflammatory drugs
- 133. The natural history of childhood asthma
- Index
